Neuroendocrine stimulation of mucosal immune cells in inflammatory bowel disease

Current Pharmaceutical Design

Volumn 20, Issue 29, 2014, Pages 4766-4773

  Martín Villa, José M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Gut brain immune system axis; Ibd (inflammatory bowel disease); Stress; T lymphocytes; Tlr; Vip

Indexed keywords

CD45RA ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CELL STRESS; DENDRITIC CELL; GENETIC PREDISPOSITION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INTESTINE CELL; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; INTESTINE LYMPHATIC TISSUE; INTRAEPITHELIAL LYMPHOCYTE; LAMINA PROPRIA; LYMPHOCYTE; MESENTERY LYMPH NODE; MONONUCLEAR CELL; MUCOSAL IMMUNITY; NEUROENDOCRINE STIMULATION; PANETH CELL; PATHOGENESIS; PEYER PATCH; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE; BRAIN; IMMUNOLOGY; LYMPHOID TISSUE; NEUROSECRETION; PATHOPHYSIOLOGY;

BRAIN; HUMANS; IMMUNITY, MUCOSAL; INFLAMMATORY BOWEL DISEASES; LYMPHOID TISSUE; NEUROSECRETORY SYSTEMS;

EID: 84906239382     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140130205058     Document Type: Article

References (67)

1. Castro-Sanchez P, Martin-Villa JM. Gut immune system and oral tolerance. Br J Nutr 2013; 109 Suppl 2: S3-S11.
2. McGhee JR, Mestecky J, Dertzbaugh MT, Eldridge JH, Hirasawa M, Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992; 10(2): 75-88.
3. Ponda PP, Mayer L. Mucosal epithelium in health and disease. Curr Mol Med 2005; 5(6): 549-556.
4. Baumgart DC, Dignass AU. Intestinal barrier function. Curr Opin Clin Nutr Metab Care 2002; 5(6): 685-694.
5. Moens E, Veldhoen M. Epithelial barrier biology: good fences make good neighbours. Immunology 2012; 135(1): 1-8.
6. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004; 25(11): 570-577.
7. Brandtzaeg P, Kiyono H, Pabst R, Russell MW. Terminology: nomenclature of mucosa-associated lymphoid tissue. Mucosal Immunol 2008; 1(1): 31-37.
8. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003; 3(4): 331-341.
9. Mowat AM, Millington OR, Chirdo FG. Anatomical and cellular basis of immunity and tolerance in the intestine. J Pediatr Gastroen-terol Nutr 2004; 39 Suppl 3: S723-S724.
10. Johansen FE, Kaetzel CS. Regulation of the polymeric immuno-globulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mu-cosal immunity. Mucosal Immunol 2011; 4(6): 598-602.
11. Cheroutre H, Lambolez F, Mucida D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 2011; 11(7): 445-456.
12. Leon F. Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease. J Immunol Methods 2011; 363(2): 177-186.
13. Brandtzaeg P. Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 2009; 70(6): 505-515.
14. Rocha B. The extrathymic T-cell differentiation in the murine gut. Immunol Rev 2007; 215: 166-177.
15. Rocha B, Guy-Grand D, Vassalli P. Extrathymic T cell differentiation. Curr Opin Immunol 1995; 7(2): 235-242.
16. Howie D, Spencer J, DeLord D, et al. Extrathymic T cell differentiation in the human intestine early in life. J Immunol 1998; 161(11): 5862-5872.
17. Pickard JM, Chervonsky AV. Sampling of the intestinal microbiota by epithelial M cells. Curr Gastroenterol Rep 2010; 12(5): 331-339.
18. Yamamoto M, Pascual DW, Kiyono H. M cell-targeted mucosal vaccine strategies. Curr Top Microbiol Immunol 2012; 354: 39-52.
19. Blumberg RS, Lencer WI, Zhu X, et al. Antigen presentation by intestinal epithelial cells. Immunol Lett 1999; 69(1): 7-11.
20. Rescigno M. Intestinal dendritic cells. Adv Immunol 2010; 107: 109-138.
21. Rescigno M, Urbano M, Valzasina B, et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001; 2(4): 361-367.
22. Gewirtz AT, Madara JL. Periscope, up! Monitoring microbes in the intestine. Nat Immunol 2001; 2(4): 288-290.
23. Pabst R, Rothkotter HJ. Structure and function of the gut mucosal immune system. Adv Exp Med Biol 2006; 579: 1-14.
24. Sanz Y, De Palma G. Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function. Int Rev Immunol 2009; 28(6): 397-413.
25. Rodriguez-Juan C, Perez-Blas M, Suarez-Garcia E, et al. Lens culinaris, Phaseolus vulgaris and vicia faba lectins specifically trigger IL-8 production by the human colon carcinoma cell line CACO-2. Cytokine 2000; 12(8): 1284-1287.
26. Rodriguez-Juan C, Perez-Blas M, Valeri AP, et al. Cell surface phenotype and cytokine secretion in Caco-2 cell cultures: increased RANTES production and IL-2 transcription upon stimulation with IL-1beta. Tissue Cell 2001; 33(6): 570-579.
27. Martin-Villa JM, Ferre-Lopez S, Lopez-Suarez JC, Corell A, Perez-Blas M, Arnaiz-Villena A. Cell surface phenotype and ul-tramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine. Tissue Antigens 1997; 50(6): 586-592.
28. Abadie V, Sollid LM, Barreiro LB, Jabri B. Integration of genetic and immunological insights into a model of celiac disease patho-genesis. Annu Rev Immunol 2011; 29: 493-525.
29. Dwinell MB, Johanesen PA, Smith JM. Immunobiology of epithelial chemokines in the intestinal mucosa. Surgery 2003; 133(6): 601-607.
30. Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcera-tive colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007; 132(2): 507-515.
31. Schreiber S, Raedler A, Stenson WF, MacDermott RP. The role of the mucosal immune system in inflammatory bowel disease. Gas-troenterol Clin North Am 1992; 21(2): 451-502.
32. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140(6): 1756-1767.
33. Pallone F, Monteleone G. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut 1998; 43(6): 735-736.
34. Stronkhorst A, Radema S, Yong SL, Bijl H, Ten Berge IJ, Tytgat GN, et al. CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study. Gut 1997; 40(3): 320-327.
35. Selby WS, Janossy G, Mason DY, Jewell DP. Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease. Clin Exp Immunol 1983; 53(3): 614-618.
36. Schreiber S, Raedler A, Conn AR, Rombeau JL, MacDermott RP. Increased in vitro release of soluble interleukin 2 receptor by colo-nic lamina propria mononuclear cells in inflammatory bowel disease. Gut 1992; 33(2): 236-241.
37. Mueller C, Knoflach P, Zielinski CC. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990; 98(3): 639-646.
38. Roman LI, Manzano L, De La Hera A, Abreu L, Rossi I, Alvarez-Mon M. Expanded CD4+CD45RO+ phenotype and defective pro-liferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 1996; 110(4): 1008-1019.
39. Aguilera-Montilla N, Perez-Blas M, Valeri AP, et al. Higher pro-liferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines. Scand J Gastroenterol 2004; 39(12): 1236-1242.
40. Aguilera-Montilla N, Perez-Blas M, Valeri AP, et al. Herpesvirus saimiri (HVS)-transformed T-cell lines: a method to study mucosal T cells in inflammatory bowel disease. Scand J Gastroenterol 2006; 41(11): 1361-1363.
41. Rubino SJ, Selvanantham T, Girardin SE, Philpott DJ. Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol 2012; 24(4): 398-404.
42. Theis MK, Boyko EJ. Patient perceptions of causes of inflammatory bowel disease. Am J Gastroenterol 1994; 89(10): 1920.
43. von Wietersheim J, Kohler T, Feiereis H. Relapse-precipitating life events and feelings in patients with inflammatory bowel disease. Psychother Psychosom 1992; 58(2): 103-112.
44. Hart AL, Plamondon S, Emmanuel AV, Kamm MA. Prospective evaluation of the relationship between stress and relapse in ulcera-tive colitis. J Clin Gastroenterol 2008; 42(8): 963-964.
45. Hart A, Kamm MA. Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Aliment Pharmacol Ther 2002; 16(12): 2017-2028.
46. Levenstein S, Prantera C, Varvo V, et al. Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res 1993; 37(1): 19-32.
47. Levenstein S, Prantera C, Varvo V, et al. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 1994; 89(8): 1219-1225.
48. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology 1994; 106(2): 287-296.
49. Meddings JB, Swain MG. Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology 2000; 119(4): 1019-1028.
50. Kelly D, Mulder IE. Microbiome and immunological interactions. Nutr Rev 2012; 70 Suppl 1: S18-S30.
51. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 2008; 263(6): 597-606.
52. Lundin A, Bok CM, Aronsson L, et al. Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication that tunes innate immunity in large intestine. Cell Microbiol 2008; 10(5): 1093-1103.
53. Cario E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis 2010; 16(9): 1583-1597.
54. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metage-nomic approach. Gut 2006; 55(2): 205-211.
55. Qiu BS, Vallance BA, Blennerhassett PA, Collins SM. The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. Nat Med 1999; 5(10): 1178-1182.
56. Schleifer SJ, Keller SE, Camerino M, Thornton JC, Stein M. Suppression of lymphocyte stimulation following bereavement. JAMA 1983; 250(3): 374-377.
57. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325(9): 606-612.
58. Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev 2004; 56(2): 249-290.
59. Abad C, Gomariz R, Waschek J, et al. VIP in inflammatory bowel disease: state of the art. Endocr Metab Immune Disord Drug Targets 2012; 12(4): 316-322.
60. Ghia JE, Blennerhassett P, Deng Y, Verdu EF, Khan WI, Collins SM. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009; 136(7): 2280.e1-4-2288.e1-4.
61. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastro-enterology 2006; 131(4): 1122-1130.
62. Ghia JE, Blennerhassett P, Collins SM. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 2008; 118(6): 2209-2218.
63. Ghia JE, Blennerhassett P, Collins SM. Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007; 293(3): G560-G567.
64. Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003; 170(4): 429-433.
65. Stasi C, Orlandelli E. Role of the brain-gut axis in the pathophysi-ology of Crohn's disease. Dig Dis 2008; 26(2): 156-166.
66. Wang K, Yuan CP, Wang W, et al. Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis. World J Gastro-enterol 2010; 16(18): 2252-2259.
67. Pavlov VA, Tracey KJ. Neural regulators of innate immune responses and inflammation. Cell Mol Life Sci 2004; 61(18): 2322-2331.